Menu
- Lisa Colter
Hadassah Medical Center Researchers Tout ‘Hopeful’ Treatment Results For Myeloma Cancer
- Lisa Colter
Israeli CAR-T cancer treatment could be administered out-patient – first in the world
- Lisa Colter
Jerusalem’s Hadassah medical center named global leader in several fields
- Lisa Colter
Israeli Humanitarian Aid Delegation Departs for Türkiye
‘We’ll do our best to save lives’: IDF rescue delegation arrives in southern Turkey
- Lisa Colter
Prof. Polina Stepensky Explains The CAR (Chimeric Antigen Receptor) T-Cell Therapy.
Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today that they have entered into the research and license agreement with Immix BioPharma, for the development and commercialization of novel tissue specific therapeutics based on anti-BCMA CAR-T cells targeting plasma cell. This technology has been developed as the result of a collaboration between Prof. Polina Stepensky, of Hadassah Medical Center, Jerusalem and Prof. Cyrille J. Cohen, of Bar-Ilan University, Ramat Gan. Dr. Shlomit Kfir-Erenfeld and Dr. Nathalie Asherie, of Hadassah Medical Center, and Ortal Harush, of Bar-Ilan University, also participated in the research.
For more information visit Yahoo! Finance
- Lisa Colter
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms
Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
- Lisa Colter
COVID-19 vaccine provides effective protection against Omicron pregnancy risks
Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.
(photo credit: REUTERS/FLORENCE LO)
